Skip to main content
Log in

Stereoselective plasma protein binding of ibuprofen enantiomers

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

We have developed a novel and reproducible method for determining the plasma protein binding of the two ibuprofen enantiomers in the presence of each other. The method involves the use of radiolabelled racemic ibuprofen, equilibrium dialysis, derivatization of the enantiomers to diastereomeric amides, high-performance liquid chromatography, and radiochemical analysis.

We have determined the plasma protein binding of R(−)- and S(+)-ibuprofen in 6 healthy male volunteers after the oral administration of 800 mg racemic ibuprofen.

The mean time-averaged percentage unbound of the R(−)-enantiomer, 0.419 was significantly less than that of the S(+)-enantiomer, 0.643, consistent with stereoselective plasma protein binding.

The percentage unbound of each ibuprofen enantiomer was concentration-dependent over the therapeutic concentration range and was influenced by the presence of its optical antipode.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Adams SS, Bresloff P, Mason CG (1976) Pharmacological differences between the optical isomers of ibuprofen, evidence for metabolic inversion of the (−)-isomer. J Pharm Pharmacol 28: 256–257

    Google Scholar 

  2. Hutt AJ, Caldwell J (1983) The metabolic chiral inversion of 2-aryl propionic acids — a novel route with pharmacological consequences. J Pharm Pharmacol 35: 693–704

    Google Scholar 

  3. Lee EJD, Williams K, Day R, Graham G, Champion D (1985) Stereoselective disposition of ibuprofen enantiomers in man. Br J Clin Pharmacol 19: 663–668

    Google Scholar 

  4. Lin JH, Cocchetto DM, Duggan DE (1987) Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs. Clin Pharmacokinet 12: 402–432

    Google Scholar 

  5. Aarons L, Grennan DM, Siddiqui M (1983) The binding of ibuprofen to plasma proteins. Eur J Clin Pharmacol 25: 815–818

    Google Scholar 

  6. Williams K, Lee E (1985) Importance of drug enantiomers in clinical pharmacology. Drugs 30: 333–354

    Google Scholar 

  7. Jones ME, Sallustio BC, Purdie YT, Meffin PJ (1986) Enantioselective disposition of 2-arylpropionic acid drugs. II. 2-Phenylpropionic acid protein binding. J Pharmacol Exp Ther 238: 288–294

    Google Scholar 

  8. Ariens EJ (1984) Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. Eur J Clin Pharmacol 26: 663–668

    Google Scholar 

  9. Cox JW, Cox SR, VanGiessen G, Ruwart MJ (1985) Ibuprofen stereoisomer hepatic clearance and distribution in normal and fatty in situ perfused rat liver. J Pharmacol Exp Ther 232: 636–643

    Google Scholar 

  10. Yacobi A, Levy G (1975) Importance of assay sensitivity for plasma protein binding determinations. J Pharmacokinet Biopharm 3: 439–441

    Google Scholar 

  11. Bjornsson TD, Brown JE, Tschanz C (1981) Importance of radiochemical purity of radiolabelled drugs used for determining plasma protein binding of drugs. J Pharm Sci 70: 1372–1373

    Google Scholar 

  12. Gallo JM, Gall EP, Gillespie WR, Albert KS, Perrier D (1986) Ibuprofen kinetics in plasma and synovial fluid of arthritic patients. J Clin Pharmacol 26: 65–70

    Google Scholar 

  13. Lockwood GF, Albert KS, Szpunar GJ, Wagner JG (1983) Pharmacokinetics of ibuprofen in man-III: Plasma protein binding. J Pharmacokinet Biopharm 11: 469–482

    Google Scholar 

  14. Huang J (1983) Errors in estimating the unbound fraction of drugs due to the volume shift in equilibrium dialysis. J Pharm Sci 72: 1368–1369

    Google Scholar 

  15. Tozer TN (1984) Protein binding estimates in the presence of volume shifts during equilibrium dialysis. In: Benet LZ, Levy G, Ferraiolo BL (eds) Pharmacokinetics: A modern view. Plenum Press, New York London

    Google Scholar 

  16. Yacobi A, Levy G (1977) Protein binding of warfarin enantiomers in serum of humans and rats. J Pharmacokinet Biopharm 5: 123–131

    Google Scholar 

  17. Ofori-Adjei D, Ericsson O, Sjöqvist F (1986) Protein binding of chloroquine enantiomers and desethylchloroquine. Br J Clin Pharmacol 22: 356–358

    Google Scholar 

  18. Eichelbaum M, Mikus G, Vogelsang B (1984) Pharmacokinetics of (+)-, (−)- and (±)-verapamil after intravenous administration. Br J Clin Pharmacol 17: 453–458

    Google Scholar 

  19. Rendic S, Alebic-Kolbah T, Kajfez F, Sunjic V (1980) Stereoselective binding of (+)- and (−)-α (benzoylphenyl)propionic acid (ketoprofen) to human serum albumin. Farmaco [Sci] 35: 51–59

    Google Scholar 

  20. Knadler MP, Brater DC, Hall SD (1988) Stereoselective plasma protein binding of flurbiprofen. Clin Pharmacol Ther 44: 135

    Google Scholar 

  21. Sudlow G, Birkett DJ, Wade DN (1976) Further characterization of specific drug binding sites on human serum albumin. Mol Pharmacol 12: 1052–1061

    Google Scholar 

  22. Jahnchen E, Muller WE (1983) Stereoselectivity in protein binding and drug distribution. In: Breimer DD, Speiser P (eds) Topics in Pharmaceutical Sciences 1983. Elsevier, Amsterdam

    Google Scholar 

  23. Muller WE, Wollert U (1975) High stereospecificity of the benzodiazepine binding site on human serum albumin. Studies with d- and l-oxazepam hemisuccinate. Mol Pharmacol 11: 52–60

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Evans, A.M., Nation, R.L., Sansom, L.N. et al. Stereoselective plasma protein binding of ibuprofen enantiomers. Eur J Clin Pharmacol 36, 283–290 (1989). https://doi.org/10.1007/BF00558161

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00558161

Key words

Navigation